Spanish Red Biotech Pipeline

MSD

Pembrolizumab

Type: Biodrugs/ Drugs
Therapeutic area: Cancer
Indication: Pembrolizumab in recurrent or metastatic cutaneous squamous cell carcinoma
Phase: 2Phase II in Spain, 1Phase I